Graphene Oxide

Graphene Oxide (GO) is a chemically modified derivative of Graphene — a single-layer sheet of carbon atoms arranged in a two-dimensional hexagonal lattice — in which oxygen-containing functional groups (hydroxyl, epoxide, carbonyl, and carboxyl groups) have been introduced across the carbon surface. This oxidation process makes graphene oxide water-dispersible, highly biocompatible with certain biological systems, and amenable to further chemical functionalisation, properties that have made it an object of intense interest in nanomedicine, materials science, and — following independent research conducted during the COVID-19 pandemic era — in alternative research communities investigating undisclosed components in pharmaceutical products.

Graphene oxide sits at the intersection of Nanotechnology, mRNA Technology, and Biosurveillance concerns. While mainstream scientific literature presents GO primarily as a promising drug delivery platform and biosensor substrate, a growing body of independent research alleges its undisclosed presence in COVID-19 vaccine formulations and raises questions about its potential role in enabling intra-body nanotechnological networks.

A physical sample of graphene oxide material, showing its characteristic appearance as a dry powder or flake.

Chemical Structure and Properties

Graphene oxide is produced by treating graphite with strong oxidising agents — a process first described by chemist Benjamin Brodie in 1859, and later refined through the Hummers method, which remains the most widely used synthesis route today.

Its key properties include:

• Amphiphilicity: GO contains both hydrophilic (water-attracting) and hydrophobic (water-repelling) regions, enabling it to interact with a wide range of biological and chemical environments.
• Large surface area: A single sheet of GO presents an enormous surface area relative to its mass, allowing it to carry substantial payloads of drugs, genetic material, or other agents.
• Electrical conductivity: Partially reduced graphene oxide (rGO) can conduct electricity, a property with implications for in-body electronic applications. See Intra-Body Nano Network.
• Fluorescence quenching: GO can suppress fluorescence signals, a property exploited in biosensor design. See Biosensors and Surveillance.
• Electromagnetic responsiveness: GO and rGO structures exhibit sensitivity to specific electromagnetic frequencies, including those within the microwave and terahertz spectrum. Some researchers have proposed this makes GO-based structures responsive to 5G network frequencies. See Electromagnetic Activation of Nanodevices.
• Self-assembly potential: Under certain conditions of pH, temperature, or electromagnetic stimulation, GO sheets can organise into three-dimensional structures. See Self-Assembling Nanostructures.
• Toxicity profile: GO exhibits dose-dependent cytotoxicity — at certain concentrations it causes oxidative stress, membrane disruption, and cell death. At lower concentrations its effects remain an area of active and contested research. See Nanotoxicology.

Documented Scientific Applications

Within mainstream nanomedicine and materials science, graphene oxide has been investigated for the following applications:

Drug and Gene Delivery

GO's large surface area and functional groups allow it to bind to a wide range of drug molecules and nucleic acids. Researchers have demonstrated its use as a carrier vehicle for:

• Chemotherapy agents targeting tumour cells
• CRISPR gene-editing components
• Small interfering RNA (siRNA) for gene silencing
• mRNA constructs for vaccine and therapeutic applications

This places GO in direct functional overlap with Lipid Nanoparticles, which serve a similar delivery role in current mRNA vaccine platforms.

Biosensors

GO-based biosensors have been developed for detecting cancer biomarkers, pathogens, and environmental toxins with extraordinary sensitivity. The ability to functionalise GO surfaces with antibodies or DNA probes makes it a versatile substrate for detection applications. See Biosensors and Surveillance.

Neural Interfaces

GO and rGO have been used experimentally as electrode coatings in brain-computer interface research, owing to their biocompatibility with neural tissue and electrical conductivity. Some researchers at institutions including MIT and the University of Manchester have investigated GO-based scaffolds for neural regeneration and recording. See Neural Nanotechnology.

Antibacterial and Antiviral Coatings

GO coatings have demonstrated antibacterial properties and have been applied to medical surfaces and textiles. Some research has explored its antiviral properties, though these findings remain preliminary.

Graphene Oxide in COVID-19 Vaccines: The Independent Research Findings

The question of whether graphene oxide was present in COVID-19 vaccine formulations — and whether its presence was disclosed — became one of the most significant and contested areas of independent research from 2021 onwards.

La Quinta Columna

In June 2021, Spanish researchers Ricardo Delgado and Dr. José Luis Sevillano of La Quinta Columna published a preliminary report claiming that graphene oxide had been identified as a primary component of the Pfizer-BioNTech COVID-19 vaccine vial contents, based on analysis commissioned from University of Almería researcher Dr. Pablo Campra.

The initial report was later supplemented by a full technical paper in which Dr. Campra reported the use of micro-Raman spectroscopy — a standard analytical chemistry technique for identifying carbon-based nanomaterials — to identify structures in vaccine samples consistent with graphene-family nanomaterials (GFN). The findings were characterised as preliminary but significant, warranting further independent investigation.

Dr. Pablo Campra's Raman Spectroscopy Analysis

Dr. Pablo Campra's Raman spectroscopy study identified spectral signatures in vaccine samples that matched the characteristic D and G bands associated with graphene-family nanomaterials. His report noted the presence of:

• Reduced graphene oxide (rGO)
• Graphene quantum dots
• Other carbon-based nanomaterial structures

The research was published independently and has not been peer-reviewed through conventional journals, though supporters argue that mainstream journals have declined to engage with its findings for non-scientific reasons.

Dr. Shimon Yanowitz

Dr. Shimon Yanowitz conducted electrical conductivity testing on vaccine vial contents, reporting anomalous results inconsistent with declared biological contents. His work has been cited alongside the Campra findings as corroborating evidence of undisclosed electrically conductive nanomaterials.

Dr. Ana Maria Mihalcea

Dr. Ana Maria Mihalcea has documented what she describes as self-assembling nanostructures in blood samples from vaccinated individuals using darkfield microscopy. Her research repeatedly references graphene oxide as a candidate material for some of the observed formations, citing its self-assembly properties and electromagnetic responsiveness. See Self-Assembling Nanostructures and Live Blood Analysis.

Official Response

Pharmaceutical manufacturers and regulatory bodies including the FDA and EMA have consistently denied the presence of graphene oxide in vaccine formulations. Mainstream fact-checking organisations have characterised the claims as misinformation. Independent researchers counter that the methods used to dismiss these findings — primarily reliance on manufacturer declarations rather than independent spectroscopic analysis — are inadequate.

Graphene Oxide and the Intra-Body Nano Network

Some researchers have proposed that if graphene oxide is present within biological systems in sufficient quantities, it could serve as a substrate for an Intra-Body Nano Network — a theorised system of nanoscale components operating within the human body and potentially communicating with external networks via electromagnetic frequencies.

The specific properties of GO that make it relevant to this hypothesis include:

• Electrical conductivity: rGO in particular can form conductive pathways within tissue.
• Electromagnetic responsiveness: GO structures may act as antennas capable of receiving or transmitting signals, particularly in the GHz frequency ranges associated with 5G networks.
• Self-assembly: Under the right conditions, GO sheets organise into larger structures — potentially including antenna-like or circuit-like formations.
• Biocompatibility: GO can persist within biological systems without triggering immediate immune rejection, particularly when functionalised to mimic biological molecules. See Immune Evasion and Nanoparticles.

According to researchers including Mik Andersen (Corona2Inspect), the structural formations observed in post-injection blood samples are consistent with designed nanotechnological systems utilising graphene-family materials as a core component. See Self-Assembling Nanostructures and Intra-Body Nano Network.

Toxicology and Health Concerns

Even within mainstream scientific literature, the toxicology of graphene oxide is a subject of active research and genuine uncertainty.

Documented concerns include:

• Pulmonary toxicity: Inhaled GO particles have been shown to cause lung inflammation and oxidative stress in animal models. This is directly relevant to concerns about Aerosol Delivery of Nanoparticles.
• Genotoxicity: Some studies have identified DNA damage associated with GO exposure at certain concentrations.
• Haematological effects: GO has been shown to interact with red blood cells, potentially causing haemolysis (cell rupture) and aggregation at higher concentrations.
• Oxidative stress: GO is a potent generator of reactive oxygen species (ROS), which at elevated levels damage cellular structures and contribute to inflammation.
• Neurological penetration: Some research suggests GO nanoparticles may cross the blood-brain barrier, raising concerns about neurological effects. See Neural Nanotechnology and Neuroweapons.
• Long-term accumulation: The fate of GO within biological systems over extended timeframes — including whether it is excreted, degraded, or accumulates in organs — remains poorly characterised. See Nanotoxicology.

Regulatory and Disclosure Concerns

A central concern raised by independent researchers is not merely whether GO is present in pharmaceutical or environmental products, but whether its presence is disclosed and whether adequate safety testing has been conducted.

Critics of current regulatory frameworks point to:

• The absence of mandatory nanomaterial disclosure requirements for pharmaceutical products in most jurisdictions.
• The FDA's track record of regulatory capture by pharmaceutical interests.
• The lack of independent, third-party spectroscopic analysis of vaccine vial contents mandated by regulators.
• The suppression or dismissal of independent research findings without substantive scientific rebuttal.

See Informed Consent, Regulatory Capture, and Nanotech Ethics.

Graphene Oxide and Electromagnetic Frequency

One of the more controversial aspects of graphene oxide research concerns its relationship to electromagnetic frequency — specifically whether GO-based structures within biological systems could be activated, modulated, or weaponised via external electromagnetic signals.

Some researchers, including those associated with La Quinta Columna, have proposed that the rollout of 5G telecommunications infrastructure in parallel with COVID-19 vaccine programmes was not coincidental — suggesting that 5G frequencies may interact with GO-based in-body structures to produce biological effects including oxidative stress, altered nerve signalling, or remote modulation of physiological states.

While this hypothesis remains highly contested and unproven in peer-reviewed literature, the electromagnetic properties of graphene-family nanomaterials are well-documented within mainstream materials science. See Electromagnetic Activation of Nanodevices and 5G.

Related Topics

• Graphene
• Nanotechnology
• Lipid Nanoparticles
• mRNA Technology
• COVID Vaccines
• Self-Assembling Nanostructures
• Intra-Body Nano Network
• Internet of Bodies
• 5G
• Biosensors and Surveillance
• Neural Nanotechnology
• Nanotoxicology
• Immune Evasion and Nanoparticles
• Aerosol Delivery of Nanoparticles
• Chemtrails
• Brain-Computer Interface
• CRISPR
• Nanoparticles in Vaccines
• Dr. Ana Maria Mihalcea
• Dr. Pablo Campra
• Ricardo Delgado
• La Quinta Columna
• Mik Andersen
• Dr. Shimon Yanowitz
• Informed Consent
• Regulatory Capture
• Electromagnetic Activation of Nanodevices

External References and Further Reading

• Dr. Pablo Campra — Detection of Graphene in COVID19 Vaccines by Micro-Raman Spectroscopy (2021, independent publication)
• La Quinta Columna — Published reports and video documentation on graphene oxide findings
• Dr. Ana Maria Mihalcea — Ana's Substack: ongoing documentation of blood sample findings and GO-related nanostructure research
• Mik Andersen (Corona2Inspect) — Technical analyses of self-assembling nanostructures and graphene-family material identification
• Novoselov, K.S. & Geim, A.K. (2004) — Foundational graphene research, University of Manchester (Nobel Prize in Physics, 2010)
• Dreyer, D.R. et al. (2010) — The Chemistry of Graphene Oxide, Chemical Society Reviews
• NIH — PubMed-indexed literature on graphene oxide toxicology and nanomedicine applications